Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis.

Pinal-Fernandez I, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL.

J Rheumatol. 2015 Aug;42(8):1448-54.

2.

Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases.

Lloyd TE, Christopher-Stine L, Pinal-Fernandez I, Tiniakou E, Petri M, Baer A, Danoff SK, Pak K, Casciola-Rosen LA, Mammen AL.

Arthritis Care Res (Hoboken). 2016 Jan;68(1):66-71. doi: 10.1002/acr.22600.

3.

Association of the autoimmune disease scleroderma with an immunologic response to cancer.

Joseph CG, Darrah E, Shah AA, Skora AD, Casciola-Rosen LA, Wigley FM, Boin F, Fava A, Thoburn C, Kinde I, Jiao Y, Papadopoulos N, Kinzler KW, Vogelstein B, Rosen A.

Science. 2014 Jan 10;343(6167):152-7. doi: 10.1126/science.1246886. Epub 2013 Dec 5.

4.

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.

Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casciola-Rosen LA.

Arthritis Rheum. 2011 Mar;63(3):713-21. doi: 10.1002/art.30156.

5.

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.

Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL.

Arthritis Rheum. 2010 Sep;62(9):2757-66. doi: 10.1002/art.27572.

6.

Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle.

Mammen AL, Casciola-Rosen LA, Hall JC, Christopher-Stine L, Corse AM, Rosen A.

Arthritis Rheum. 2009 Dec;60(12):3784-93. doi: 10.1002/art.24977.

7.

Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis.

Levine SM, Raben N, Xie D, Askin FB, Tuder R, Mullins M, Rosen A, Casciola-Rosen LA.

Arthritis Rheum. 2007 Aug;56(8):2729-39.

8.
9.

Methods for inducing apoptosis.

Roberts KM, Rosen A, Casciola-Rosen LA.

Methods Mol Med. 2004;102:115-28.

PMID:
15286383
10.

Granzyme B-induced cell death.

Andrade F, Casciola-Rosen LA, Rosen A.

Acta Haematol. 2004;111(1-2):28-41. Review.

PMID:
14646343
11.

Anti-aminoacyl tRNA synthetase immune responses: insights into the pathogenesis of the idiopathic inflammatory myopathies.

Levine SM, Rosen A, Casciola-Rosen LA.

Curr Opin Rheumatol. 2003 Nov;15(6):708-13. Review.

PMID:
14569199
13.

Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death.

Andrade F, Bull HG, Thornberry NA, Ketner GW, Casciola-Rosen LA, Rosen A.

Immunity. 2001 Jun;14(6):751-61.

14.

The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen.

Casciola-Rosen LA, Pluta AF, Plotz PH, Cox AE, Morris S, Wigley FM, Petri M, Gelber AC, Rosen A.

Arthritis Rheum. 2001 Feb;44(2):389-96.

15.

Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis.

Mancini M, Machamer CE, Roy S, Nicholson DW, Thornberry NA, Casciola-Rosen LA, Rosen A.

J Cell Biol. 2000 May 1;149(3):603-12.

16.

The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling.

Mancini M, Nicholson DW, Roy S, Thornberry NA, Peterson EP, Casciola-Rosen LA, Rosen A.

J Cell Biol. 1998 Mar 23;140(6):1485-95.

17.
18.
20.

Ligand binding and processing. The perfused liver as a model system.

Renfrew CA, Casciola-Rosen LA, Hubbard AL.

Methods Mol Biol. 1994;27:325-41. No abstract available.

PMID:
8298701
21.
22.
23.

Supplemental Content

Loading ...
Support Center